Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDIdera Pharmaceuticals, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 06/29/2023 | Q1 2023 | N/A | -$0.00 | N/A | N/A | $0 |
| 04/13/2023 | Q4 2022 | N/A | -$3.30 | N/A | N/A | $-49,000 |
| 11/14/2022 | Q3 2022 | N/A | -$0.99 | N/A | N/A | $49,000 |
| 08/09/2022 | Q2 2022 | N/A | -$1.72 | N/A | N/A | $0 |
| 05/05/2022 | Q1 2022 | N/A | -$1.34 | N/A | N/A | $0 |
| 03/31/2022 | Q4 2021 | -$0.11 | -$1.33 | -1.22 | N/A | $0 |
| 11/08/2021 | Q3 2021 | -$0.12 | -$1.92 | -1.8 | N/A | $0 |
| 08/09/2021 | Q2 2021 | -$0.18 | -$2.58 | -2.4 | N/A | $0 |
| 04/29/2021 | Q1 2021 | -$0.21 | $47.76 | 47.97 | N/A | $0 |
| 03/01/2021 | Q4 2020 | -$0.23 | -$35.95 | -35.72 | N/A | $0 |
| 10/29/2020 | Q3 2020 | -$0.22 | -$9.96 | -9.74 | N/A | $0 |
| 08/04/2020 | Q2 2020 | -$0.39 | -$12.26 | -11.87 | N/A | $0 |
| 04/30/2020 | Q1 2020 | -$0.41 | $4.95 | 5.36 | N/A | $0 |
| 03/11/2020 | Q4 2019 | -$0.35 | -$13.54 | -13.19 | N/A | $-1,448,000 |
| 11/06/2019 | Q3 2019 | -$0.46 | -$6.56 | -6.1 | N/A | $0 |
| 08/08/2019 | Q2 2019 | -$0.42 | -$6.68 | -6.26 | N/A | $1.45 M |
| 05/02/2019 | Q1 2019 | -$0.46 | -$6.74 | -6.28 | N/A | $0 |
| 03/06/2019 | Q4 2018 | -$0.51 | -$7.60 | -7.09 | N/A | $99,000 |
| 11/06/2018 | Q3 2018 | -$0.58 | -$7.26 | -6.68 | N/A | $145,000 |
| 08/02/2018 | Q2 2018 | -$0.82 | -$10.04 | -9.22 | N/A | $163,000 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Idera Pharmaceuticals, Inc. Earnings: FAQ's
The conference call for Idera Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Idera Pharmaceuticals, Inc.'s latest earnings report can be read online.
Idera Pharmaceuticals, Inc. (:IDRA) has a recorded net income of $-23,360,000.Idera Pharmaceuticals, Inc. has generated $-7.18 earnings per share over the last four quarters.
Idera Pharmaceuticals, Inc. (:IDRA) has a price-to-earnings ratio of -0.06 and price/earnings-to-growth ratio is -0.